| P50 | author | Jianyun Yan | Q59683819 |
| | Shegufta Razzaque | Q59688077 |
| P2093 | author name string | David S Park | |
| | Lu Zhang | |
| | Jun Hu | |
| | Lei Bu | |
| | Chen-Leng Cai | |
| | Akshay Shekhar | |
| | Nishat Sultana | |
| P2860 | cites work | Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects | Q21134934 |
| | Mutation in myosin heavy chain 6 causes atrial septal defect | Q24296801 |
| | Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy | Q24306812 |
| | Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block | Q24338156 |
| | Generalized lacZ expression with the ROSA26 Cre reporter strain | Q27860837 |
| | Development of heart valves requires Gata4 expression in endothelial-derived cells | Q27863348 |
| | Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation | Q28509085 |
| | Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart | Q28594286 |
| | Congenital heart disease: entering a new era of human genetics. | Q52647783 |
| | Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. | Q54609364 |
| | Notch Signaling Contributes to the Expression of Cardiac Markers in Human Circulating Progenitor Cells | Q58816239 |
| | Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart | Q70162261 |
| | Widespread recombinase expression using FLPeR (flipper) mice | Q73266365 |
| | MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure | Q79922459 |
| | The incidence of congenital heart disease | Q29614195 |
| | A robust and high-throughput Cre reporting and characterization system for the whole mouse brain | Q29616609 |
| | Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions | Q30303899 |
| | New approaches in small animal echocardiography: imaging the sounds of silence | Q30461404 |
| | Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers | Q30469176 |
| | Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse | Q33590571 |
| | Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice | Q33790139 |
| | Complex genetics and the etiology of human congenital heart disease | Q33790650 |
| | The Notch pathway controls fibrotic and regenerative repair in the adult heart | Q34071933 |
| | Inducible gene expression and gene modification in transgenic mice | Q34077415 |
| | The molecular genetics of congenital heart disease: a review of recent developments | Q34100720 |
| | Hand2 function in second heart field progenitors is essential for cardiogenesis. | Q34574679 |
| | Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice | Q35087050 |
| | Smad4 regulates ureteral smooth muscle cell differentiation during mouse embryogenesis | Q35225701 |
| | Genetic modification of the heart: exploring necessity and sufficiency in the past 10 years | Q35769478 |
| | Generation of a tamoxifen inducible Tnnt2MerCreMer knock-in mouse model for cardiac studies | Q35779565 |
| | Developmental regulation of myosin gene expression in mouse cardiac muscle | Q36224282 |
| | With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure | Q37101602 |
| | Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. | Q37287468 |
| | Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. | Q37287472 |
| | Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis | Q37597645 |
| | System for tamoxifen-inducible expression of cre-recombinase from the Foxa2 locus in mice | Q38502825 |
| | Inducible site-directed recombination in mouse embryonic stem cells | Q39715564 |
| | Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure | Q41887614 |
| | Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models | Q42560803 |
| | Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice | Q42923082 |
| | Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei | Q43195307 |
| | Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein | Q43664631 |
| | Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. | Q48505009 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tamoxifen | Q412178 |
| P304 | page(s) | e0133472 | |
| P577 | publication date | 2015-07-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A Murine Myh6MerCreMer Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction | |
| P478 | volume | 10 | |